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This review summarizes evidence that supports working hypotheses for the roles of boron in animal model systems. It is well established that vas-
cular plants, diatoms, and some species of marine algal flagellates have acquired an absolute requirement for boron, although the primary role of
boron in plants remains unknown. Recent research findings suggest that physiologic amounts of supplemental dietary boron (PSB) affect a wide
range of metabolic parameters in the chick and rat model systems. Much of the current interest in boron animal nutrition began with the initial find-
ing that PSB stimulates growth in cholecalciferol (vitamin D3)-deficient chicks, but does not markedly affect growth in chicks receiving adequate vita-
min D3 nutriture. The finding suggests that boron affects some aspect of vitamin D3 metabolism or is synergistic with vitamin D3 in influencing
growth. Vitamin D3 regulates energy substrate utilization, and current research findings indicate that dietary boron modifies that regulatory function.
The concentration of circulating glucose, the most thoroughly investigated metabolite to date, responds to PSB, especially during concomitant vita-
min D3 deficiency. In chicks, PSB substantially alleviated or corrected vitamin D3 deficiency-induced elevations in plasma glucose concentrations.
The influence of vitamin D3 on cartilage and bone mineralization is mediated in part through its role as a regulator of energy substrate utilization; cal-
cification is an energy-intensive process. There is considerable evidence that dietary boron alleviates perturbations in mineral metabolism that are
characteristic of vitamin D3 deficiency. In rachitic chicks, PSB alleviated distortion of the marrow sprouts of the proximal tibial epiphysial plate, a dis-
tortion characteristic of vitamin D3 deficiency. In ovo injections of boron or 1,25-OH)2-vitamin D3 reduced the abnormal height of the growth plate
of 1-day-old chicks hatched from vitamin D3-deficient eggs. Also, in vitamin D-deficient rats, PSB improved the apparent absorption and retention of
calcium and phosphorus, and increased femur magnesium concentrations. Current findings lend support to the hypothesis that boron alleviates the
symptoms of vitamin D3-deficiency by enhancing utilization or sparing minimal supplies of an active vitamin D3 metabolite. Also, boron and vitamin
D3 have the same overall effect on the local utilization of energy substrates. A corollary of the hypothesis is that some of the effects of dietary boron
will be overshadowed by the effects of adequate amounts of dietary vitamin D3.- Environ Health Perspect 102(Suppl 7): 35-43 (1994)
Key words: boron, vitamin D3, boron analysis, rats, chickens, energy substrate utilization, glucose, growth cartilage, mineral metabolism, calcium,
magnesium, boron, homeostasis
Introduction
Dietary Boron and Body Growth
Much of the current interest in boron ani-
mal nutrition began in 1981 with the find-
ing that physiologic amounts of boron (3
mg/kg diet), when added to diets low in
boron content (<0.3 mg/kg diet), stimulat-
ed growth in vitamin D3-deficient (125
IU/kg) chicks. Boron supplementation did
not markedly affect growth in chicks that
received ample vitamin D3 nutriture of
2500 IU/kg (Table 1) (1). Vitamin D3
must be converted to metabolically active
forms before it can function. The first oblig-
atory enzymatic conversion to 25-hydrox-
yvitamin D3 occurs in the liver. In the kid-
ney, a major site of 25-hydroxyvitamin D3
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metabolism, an enzymatic reaction converts
some of the circulating 25-hydroxyvitamin
D3 to 1,25-dihydroxyvitamin D3. 1,25-
Dihydroxyvitamin D3, the hormonal form
ofthe vitamin, is degraded to calcitroic acid,
which is thought to represent a major inacti-
vation route ofthe hormone (2). The find-
ings from the boron feeding study suggested
that boron affected some aspect of vitamin
D3 metabolism or was synergistic with vita-
min D3 to influence growth.
In a subsequent series of experiments,
the dietary concentrations of calcium or
magnesium were manipulated to examine
the interaction between dietary boron and
vitamin D3. Magnesium deficiency was
Table 1. Effect of boron, vitamin D , and their interaction on body weight and plasma alkaline
phosphatase in chicks (1).
Treatmenta Plasma alkaline
Boron Vitamin D3 Bodyweight b phosphatase activity,
mg/kg lU/kg g units c
0 125 561 4.65
3 125 775 2.93
0 2500 896 1.77
3 2500 994 1.75
Analysis of variance-pvalues
Boron 0.0002 0.000
Vitamin D3 0.0001 0.0001
Boron x vitamin D3 NS 0.0005
aAmounts of boron (orthoboric acid) and vitamin D3 supplemented to the basal diet (0.28 mg boron/kg). bAt age 32
days. cUnits were pmoles ofp-nitrophenyl phosphate split/min/ml of plasma.
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calcium (3). a
Treatment b Plasma
Boron Vitamin D3 Bodyweight c Alkaline phosphatase Ca Mg pe B
mg/kg lU/kg g activity unitsd pg/ml pg/mI pm/gml ng/ml
0 125 730 4.04 72 12.4 114 191
3 125 666 4.41 64 10.5 101 263
0 2500 785 1.77 81 11.1 134 225
3 2500 800 1.61 74 10.1 128 311
Analysis ofvariance-pvalues
Boron NSf NS 0.0008 0.003 0.04 0.001
Vitamin D3 0.0001 0.0001 0.0001 NS 0.0001 NS
Boron xVitamin D3 0.03 NS NS NS NS NS
a20 g Ca as CaCO3/kg diet; 500 mg Mg asMg(C2H302)2 x H20/kg diet. bAmounts of boron (orthoboric acid) and
vitamin D3 supplemented to the basal diet (-0.3 mg boron/kg). cAt age 29 days. dUnits were pmoles of p-nitro-
phenyl phosphate split/min/ml of plasma. eTotal (inorganic + organic) phosphorus. INS, nonsignificant; p> 0.05
Table 3. Effect of boron, vitamin D3, and their interaction on selected variables in magnesium-deficient
chicks (3). a
Treatment b Plasma
Boron Vitamin D3 Bodyweight c Alkaline phosphatase Ca Mg pe B
mg/kg lU/kg g activity, unitsd pg/ml pg/ml pm/gml ng/ml
0 250 444 3.91 81 11.9 71 35
3 250 510 2.62 85 12.0 78 126
0 2500 765 1.11 109 11.8 73 60
3 2500 811 1.05 107 12.9 76 149
Analysis ofvariance-pvalues
Boron 0.03 0.007 NS' NS 0.01 0.0001
Vitamin D3 0.0001 0.0001 0.0001 NS NS 0.04
Boron xvitamin D3 NS 0.01 NS NS NS NS
a1g0 gCa asCaCO3/kg diet; 300 mg Mg asMg(C2H302)2x4H20/kg diet. bAmounts of boron (orthoboric acid)and
vitamin D3 supplemented to the basal diet (-0.3 mg boron/kg). cAt age 29 days. dUnits were pmoles of p-nitrophenyl
phosphate split/min/ml of plasma. elnorganic phosphorus only. INS, nonsignificant; p> 0.05
chosen as a stressor ofvitamin D3 metabo-
lism because the element is a cofactor for
the hydroxylation of 25-hydroxycholecal-
ciferol (OH) vitamin D3 (2). Findings
from boron-calcium studies (Table 2) indi-
cated that the effect ofboron supplementa-
tion on growth in chicks was eliminated
when dietary calcium was increased from
10 to 20 g/kg of diet (3). Findings from
boron-magnesium studies (Table 3) indi-
cated that growth in magnesium-deficient
chicks (300 mg Mg/kg diet) increased with
boron supplementation (3). The response
was independent of vitamin D3 intake.
However, the lowest amount ofvitamin D3
supplementation (250 IU/kg) was higher
than in earlier experiments. In general,
comparison ofthe findings on growth from
the boron-calcium and boron-magnesium
studies suggested that the relationship
between magnesium and boron was
stronger than that between calcium or
phosphorus and boron. However, the
boron:magnesium molar ratio was quite
low in both plasma and diet. Therefore, a
direct effect ofboron on magnesium metab-
olism was not suggested. Apparently, boron
indirectly influences magnesium metabo-
lism, and ultimately, calcium and phospho-
rus metabolism, by influencing an enzyme
or hormone system.
The concentration of boron in the sup-
plemented diets cited was similar to that
found in a variety of diets that contained
more natural than purified foodstuffs.
Therefore, the growth response to boron
supplementation was probably physiologic
and not pharmacologic in nature. For
example, the concentration of boron in
alfalfa was reported to be as high as 42 mg
boron/kg dry material (4). In a 10% alfalfa
ration, the amount ofboron contributed by
the alfalfa component alone would increase
the total boron concentration to 4.2 mg
boron/kg dry material. Samples of Ralston
Rodent Laboratory Chow #5001, a com-
mon diet for the laboratory rat, were found
to contain 12.1 to 13.7 mg boron/kg (5).
In several fruits and vegetables typically
consumed by humans, the concentration of
boron is at least 2 mg/kg wet weight of
material (6). Therefore, it is reasonable to
assume that a physiologic amount ofboron
was present in the experimental chick diets,
an amount defined as one within a range of
concentrations typically present in animal
or human diets.
Animal Boron Nutrition Methodology
Prior to the findings published in 1981, all
other animal boron nutrition studies were
published between 1939 and 1947.
Unfortunately, all of the earlier findings
were confounded by the use of basal diets
that were either nutritionally inadequate or
supplemented with excessive amounts of
boron (100-2200 mg/kg) (7-11). Most
findings from the earlier studies suggested
that supplemental boron did not affect
measured variables, such as growth, even
though most of the basal diets fed report-
edly contained only 0.16 to 0.45 mg
boron/kg. In one unconfirmed study (10),
supplemental dietary boron (100-1000 mg
boron/kg) enhanced survival and mainte-
nance ofbody fat, and elevated liver glyco-
gen in severely potassium-deficient rats.
The unusual technical difficulties encoun-
tered in the execution of boron nutrition
studies, which may have compromised the
findings ofthe earlier studies, justify a brief
summary of techniques used to overcome
these difficulties. The physical and chemi-
cal characteristics ofboron put special con-
straints upon diet formulations, boron
kinetic studies, and verification of dietary
boron content.
Diet Formulations
Care must be taken to ensure that basal
diets for boron nutrition research are nutri-
tionally balanced, but low in boron con-
tent. Because typical commercial diets
often contain appreciable amounts of
boron, additional supplements of dietary
boron should have negligible impact on
general metabolism. On the other hand,
balanced animal diets low in boron content
(<0.2 mg/kg) are not difficult to formu-
late. Animal muscle and milk products,
and certain plant species within the sub-
class Monocotyledoneae, such as the grami-
neous grain crops (corn, rice, wheat, bar-
ley), contain low (<0.2 mg/kg) or negligi-
ble amounts ofboron. Plant products from
species within the subclass Dicotyledoneae,
which includes fruits, nuts, and vegetables,
are major sources of dietary boron (6,12).
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Table 4. Composition of balanced basal diet for chicks
low in boron and vitamin D3. a,b
Ingredient g/kg diet
Corn, ground c, acid washed d 681.96
Casein, high protein e 160.00
Corn oil c 75.00
CaHPO4' 25.00
Mineral mix 9 27.26
CaCO3h 6.59
Iron mix 6.44
Glycine, free base 5.00
Vitamin mixk 4.89
L-arginine, free base 4.00
L-methionine i 2.50
Choline chloride' 1.30
DL-a-tocopherolc 0.06
aBasal diet contained about 0.180 mg boron on an air-
dried basis. bSupplemented with orthoboric acid
(H3BO3, Puratronic; Johnson Matthey Chemicals Ltd.,
Aesar, Seabrook, NH) and vitamin D3(vitamin D3 powder
in corn endosperm carrier; 400,000 IU/g; ICN
Biochemicals, Cleveland, Ohio) in separate mixes of
anhydrous dextrose (ICN Biochemicals). cICN
Pharmaceuticals. dCorn was acid washed with Hcl.
eTeklad, Division of Harlan Industries, Inc. (Madison,
WI). '"Baker Analyzed," J. T. Baker, Phillipsburg, NJ.
9See Table 6. hReagent, low in alkalies (MCB,
Manufacturing Chemists Inc., Cincinnati, OH). 14.50 g
iron sponge, 22 mesh (Puratronic) dissolved in 157.3 ml
of 6M HCI ("double distilled from Vycor," GFS
Chemicals, Columbus, OH) then mixed to dryness in
1610.45 g acid washed ground corn (see footnotes c and
d). When fed at 0.644% of the diet, the iron mix will
supply 59 mg iron/kg diet. iSigma (St. Louis, MO). 'See
Table 5. 'GIBCO (Grand Island, NY).
For chick or rat boron feeding studies, a
well-balanced basal diet low in boron can
be made from ground corn, high protein
casein, and corn oil supplemented with cer-
tain minerals and vitamins (Tables 4-6).
Sucrose is probably an acceptable carbohy-
drate source in boron test diets because it
contains negligible amounts of boron
(<0.015 mg/kg) (6).
Because boron leaches readily from most
laboratory glassware, neither drinking water
nor liquid reagents used in boron biological
research should come in contact with glass-
ware for any length of time. For example,
the brief time taken to quantify deionized
water volume with a standard glass volu-
metric pipet is sufficient exposure to glass to
increase the boron content of the water
sample from background concentrations to
concentrations found in plasma (0.025
pg/ml) (Hunt, unpublished observations).
The speciation ofboron in foods has not
been determined but is probably complex
and dependent upon the nature ofthe inte-
gral ligands. If boron absorption mecha-
nisms in plants and animals are analogous,
the organic forms ofboron per se are prob-
ably unavailable to animals (13). On the
other hand, the strong association between
polyhydroxyl ligands and boron is easily
and rapidly reversed by dialysis, change in
pH, heat, or the excess addition ofanother
low-molecular-weight polyhydroxyl ligand
(14). In all animal nutrition studies with
boron conducted in this laboratory, boron
was added to the experimental diets as
orthoboric acid, because it is a common
inorganic form of boron of high purity
(99.9995%) that is absorbed well from the
gastrointestinal tract (15).
Boron Kinetics
The determination of boron uptake,
turnover, and excretion in animal model
systems is hampered by the radiochemical
groperties of boron. The radioisotopes 8B,
2B, and 13B all have half-lives ofless than
one second. However, the two stable boron
isotopes, 10B and 11B, are distributed
unequally in nature (19.8 and 80.2%,
respectively). As discussed in more detail
elsewhere in this symposium, attempts are
being made to exploit this phenomenon for
the determination ofboron body pool size
and distribution by isotopic dilution and
mass spectrometry.
BoronAnalysis
The lack ofaffordable analytical capabilities
ofacceptable sensitivity is a major deterrent
to boron nutrition research. Accurate deter-
minations of low concentrations of boron
in biological substances have proven excep-
tionally difficult. The analytical difficulty is
Table 5. Composition of vitamin mix used in basal diet
for chicks.
Ingredient g/kg vitamin mix a
D-dextrose, anhydrous b 943.5583
Nicotinic acid c 20.4499
DL-pantothenic acid, calcium salt 8.1800
Riboflavin c 6.5440
Thiamine HCI c 6.5440
Pyridoxine HCI c 4.9080
Vitamin B12(0.1% in mannitol)b 4.0900
Retinyl palmitate (250,000 IU/g) 3.2720
Retinyl acetate(500,000 IU/g)b 1.6360
Folic acid c 1.2270
BiotinC 0.2045
Menadione c 0.2045
aVitamin mix, fed at 0.489% of diet, provides (per kilo-
gram ofdiet): niacin, 100 mg; Ca d-pantothenic acid, 40
mg; riboflavin, 32 mg; thiamine, 32 mg; pyridoxine, 24
mg; vitamin B12, 0.05 mg; retinyl palmitate (250,000
IU/g), 16 mg; retinyl acetate (500,000 IU/g), 8 mg;
folic acid, 6 mg; biotin, 1 mg; menadione, 1 mg. bICN
Pharmaceuticals, Inc., Life Sciences Group (Cleveland,
OH). CGIBCO, (Grand Island, NY). Newevidence suggests
thatthe requirementforvitamin K should be met by vita-
min K,(1 mg/kg) instead of menadione as recommend-
ed bythe AIN-93 diet.
Table 6. Composition of mineral mix used in basal diet
forchicks.a
Ingredient g/kg mineral mixa
Corn, ground,bacid-washed 472.5000
KCI c 209.8000
Mg(C2H302)2x4H20c 159.6000
NaCI c 137.6000
Mn(C2H302)2 x4H20d 12.3808
ZnC2H302)2x2H20 3.0814
CuS04 x5H20' 2.2010
Na2HAsO4 x7H200 0.2935
(NH4)6Mo7024 x4H20, grade 1 d 0.1467
Cr(C2H302)2 x H20, purified h 0.0734
KI, ultrapure 0.0147
Na2SeO3' 0.0110
NH4V03 0.0073
aMineral mix, fed at 2.776% of diet, provides (per kilo-
gram of diet): K, 3 g; Cl, 5 g; Mg, 490 mg; Na, 1.47 g;
Mn, 76 mg; Zn, 25 mg; Cu, 4.5 mg; As, 2 mg; Mo, 1.3
mg; Cr, 0.55 mg; I, 0.3 mg; Se, 0.1 mg; V, 90 ng. bICN
Pharmaceuticals, Inc., (Cleveland, OH). cBaker Analyzed
(J T Baker Phillipsburg, NJ). dJohnson Matthey
Chemicals Ltd. (Aesar, Seabrook, NH). eCertified ACS
(Fisher Scientific Co., Fair Lawn, NJ). fPuratronic
(Johnson Matthey Chemicals Ltd.). gCertified ACS
(Fisher Scientific Co.). 'Fisher Scientific Co. iAlfa
Products (Morton Thiokol, Inc., Danvers, MA).
exemplified by the fact that there is no cur-
rent US boron certified reference biomateri-
al. Analytical procedures commonly
employed for trace element analysis are
inappropriate for the determination of low
concentrations ofboron (<5.0 pg/g). Most
forms of glassware and chemical reagents
with background boron contamination
must be avoided. Furthermore, many boron
compounds volatize at temperatures far
below those required for most dry-ash pro-
cedures, and the extreme volatility of
boron-halide compounds exacerbates the
problem. This author has developed an eco-
nomical procedure for the digestion ofbio-
logical substances prior to boron analysis by
inductively-coupled argon plasma spec-
troscopy. The procedure circumvents many
of the problems associated with boron
analysis (16).
Guideposts to the Roles of
Boron in Animal Species
It is well established that vascular plants,
diatoms, and some species of marine algal
flagellates have acquired an absolute
requirement for boron (12,17). Even so,
the primary role of boron in those organ-
isms remains unknown. The diverse effects
of boron deficiency on plant anatomy,
physiology, and biochemistry suggest that
the element has multiple functions. There is
considerable evidence from in vitro studies
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with both plant and animal tissues that an
important role ofboron is metabolic regula-
tion, because it complexes with a variety of
substrate or reactant compounds in which
there are hydroxyl groups in favorable posi-
tions (18). For example, two classes of
enzymes are competitively inhibited in vitro
by borate or its derivatives. One class, the
oxidoreductase enzymes, which require pyri-
dine or flavin nucleotides, are inhibited as
borate competes for the NAD, or flavin
cofactor. Some examples are aldehyde dehy-
drogenase (19), xanthine oxidase (20), and
cytochrome b5 reductase (21). Borate
apparently complexes with the ribosyl cis-
hydroxy groups of NAD (22). The other
class of enzymes forms transition state ana-
logues with borate and boronic acid deriva-
tives (23). Important examples are the ser-
ine proteases, several ofwhich are key regu-
lators of the normal inflammatory process.
The coagulation factors Xa, IXa, XIa, XIIa,
activated Hageman factor, and thrombin are
serine proteases within the coagulation cas-
cade, an integral component of the inflam-
matory process. There are at least three
boronic acids which are highly effective,
slow-binding inhibitors ofthrombin (24).
Key pathways ofenergy substrate metab-
olism contain members of both classes of
enzymes that are inhibited by boron. In the
glycolytic pathway, glyceraldehyde-3-phos-
phate dehydrogenase [EC 1.2.1.12]
(GPD), which is composed of four identi-
cal subunits, converts D-glyceraldehyde-3-
phosphate to 1,3-diphosphoglycerate. ATP
and NAD+ regulate GPD activity as the
former dissociates the enzyme into dimers
and/or monomers (25), and the latter pro-
motes reassociation (26). Boron also may
regulate the enzyme, as there is evidence
from in vitro experiments that borate binds
to a specific site(s) on the enzyme that trig-
gers structural changes and dissociation of
the tetramer (27). In addition to forming a
transition-state-analogue with the enzyme,
boron also interacts with the NAD cofactor
associated with GPD (28). Competitive
inhibition with respect to NAD+ is also
observed for another NAD-requiring
enzyme of the glycolytic pathway, lactate
dehydrogenase.
The pentose-phosphate pathway in
mammalian liver generates a major part of
the NADPH required for, among other
things, fatty acid synthesis (29). In leuko-
cytes, the same pathway generates the
NADPH required for respiratory burst, the
process by which the cell produces oxidants
for attack on malignant cells, invading
organisms too large to be ingested, and cer-
tain soluble mediators. The NADPH
requirement is met by the oxidation ofglu-
cose-6-phosphate in the pentose-phosphate
pathway. In plants, one substrate of the
pentose-phosphate pathway, 6-phospho-
gluconate, is known to complex with
boron, which thereby inhibits 6-phospho-
gluconate dehydrogenase. Thus, in boron-
deficient plants, there is an increase in the
amount of substrate metabolized via the
pentose-phosphate pathway, and a decrease
in that metabolized via the Krebs
cycle (30).
The in vitro evidence for the inhibitory,
and possibly regulatory, effects ofboron on
certain enzymes in energy substrate metabo-
lism pathways, coupled with the finding
that boron exerts an apparently beneficial
effect on body growth, prompted further
investigation ofthe possible role ofboron in
energy metabolism, especially during con-
comitant vitamin D3 deficiency. The well-
known relationship between vitamin D3
and mineral/bone metabolism prompted
investigation of the role of boron in bone
morphology and metabolism as well. Thus,
the effects of boron on various aspects of
energy and mineral metabolism were exam-
ined simultaneously throughout the course
of several experiments conducted in the
author's laboratory. To facilitate discussion,
those findings are reviewed separately here.
Boron,Vitamin D3, and
Energy Substrate Utilization
VltaminD3
Classical definitions of functional vitamin
D deficiency do not adequately account for
the dissociation between plasma-calcium
concentrations, deficiency of vitamin D
metabolites, and/or bone pathology under
certain conditions (31). The complexity of
vitamin D-deficiency disease is exemplified
by the heterogeneity of pathologic condi-
tions that characterize the disease, from dia-
betes to rickets, and by the number of
intrinsic and extrinsic factors which either
enhance or alleviate expression of vitamin
D-deficiency. It was therefore important to
determine whether dietary boron is a factor
in the expression ofthe disease.
Other research showed that vitamin D3
influences energy substrate utilization as
well as mineral metabolism. Rachitic chick
bone that was incubated aerobically in vitro
consumed more glucose and released more
lactate than normal bone. When the
rachitic bone was pretreated 48 hr with
vitamin D3, the rate ofglycolysis returned
to normal (32). This effect of vitamin D3
on glycolysis may have been mediated
through calcium because calcium is one of
the main inhibitors ofphosphofructokinase
(33), a rate-limiting enzyme in the gly-
colytic pathway. In rats, cellular glycolysis
was doubled in rachitic cartilage compared
to normal cartilage. There also was a corre-
sponding increase in the activity of phos-
phofructokinase, aldolase, pyruvate kinase,
and lactate dehydrogenase (34). In vitro
consumption of glucose in rachitic chick
bone was reduced markedly by the addition
of vitamin D to the culture media (35).
Patients with chronic renal failure, com-
pared to age-and sex-matched controls,
exhibited impaired glucose tolerance and
hyperlipoproteinemia prior to therapy.
Treatment with a synthetic analogue to
active vitamin D reduced fasting blood-glu-
cose concentrations and serum triglycerides,
and improved glucose tolerance (36).
There is further evidence that vitamin
D3 is important in energy substrate utiliza-
tion. Findings from several studies with
animals and humans indicate that vitamin
D3 is essential for insulin secretion
(37-40). Various vitamin D3 metabolites
stimulated creatine kinase BB activity in
kidney and long bone diaphyses (41). Also,
dietary vitamin D3 deficiency reduced
hepatic glycogen content in rats (42). In
the same study, designed to
reexamine the hypothesis that lipid-
carbohydrate conversions do not occur in
mammalian liver, liver slices from vitamin
D3-adequate rats had a 35% increase in
glycogen content after incubation with
palmitate. Similar treatment of slices from
the vitamin D3-deficient rats yielded no
change in glycogen content. Other findings
from the study indicated that vitamin D3
treatment ofrachitic animals produced a 5-
and 4-fold increase in the activity of two
enzymes unique to the glyoxylate cycle,
isocitrate lyase, and malate synthase.
Boronand GlucoseUtilization
Because vitamin D3 regulates indices of
energy substrate utilization, and boron
improves body growth in vitamin D3-defi-
cient chicks, several studies were conducted
to determine whether an interaction
between dietary boron and vitamin D3
modifies energy substrate utilization. There
is now considerable evidence that glucose,
the most thoroughly investigated metabo-
lite to date, responds to physiologic supple-
ments of dietary boron, especially during
concomitant vitamin D3 deficiency. In an
experiment designed to test interactions
between boron, magnesium, and vitamin
D3 (Table 7) (43), dietary boron (3.04 vs
0.04 mg/kg diet) decreased the abnormally
elevated plasma-glucose concentrations by
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Table 7. Effect in chicks of dietary boron, magnesium, and vitamin D3 and their interactions on selected
variables in chicks (43).
Treatmenta Plasma
Boron Mg Vitamin D3 Body weightb Uric acid, Glucose, Albumin, Boron
mg/kg mg/kg lU/kg g mg/dl mg/dl g/dl ng/ml
0 300 125 560 6.24 327 2.42 40
3 300 125 512 7.78 418 2.24 93
0 500 125 592 6.83 463 2.36 32
3 500 125 635 5.64 329 2.29 160
0 300 625 835 6.33 327 2.31 34
3 300 625 771 7.07 315 2.25 125
0 500 625 825 7.43 337 2.36 33
3 500 625 761 6.08 317 2.13 150
Analysis ofvariance-pvalues
Boron NSC NS NS 0.0006 0.0001
Mg NS NS NS NS 0.0002
Vitamin D3 0.0001 NS 0.0001 NS NS
Boron x Mg NS 0.0003 0.0001 NS 0.0001
Mg xvitamin D3 NS NS NS NS
NS
Boron xvitamin D3 NS NS NS NS NS
Boron x Mg xvitamin D3 NS NS 0.0002 NS 0.02
aAmounts of boron (orthoboric acid), magnesium (magnesium acetate) and vitamin D3 supplemented to the basal
diet (-0.04 mg B/kg). bAtage 29 days. CNS, nonsignificant; p>0.05.
Table 8. Effect of dietary boron, magnesium, and molybdenum and their interactions on selected variables in
vitamin D3-deficient chicks (44).
Treatmenta Plasma
Boron, Mg, Mo, Bodyweight b Uric acid, Glucose, MS to CEMC
mg/kg mg/kg mg/kg g mg/dl mg/dl pm
0 300 0 418 7.99 388 -53
3 300 0 426 8.48 375 134
0 300 20 431 9.59 404 -123
3 300 20 481 6.94 334 260
0 500 0 552 8.25 453 131
3 500 0 491 6.44 369 64
0 500 20 559 6.68 367 871
3 500 20 503 6.45 385 252
Analysis ofvariance-pvalues
B NSd 0.02 0.03 NS
Mg NS 0.004 NS 0.03
Mo 0.0003 NS NS NS
BxMg NS NS NS 0.02
BxMo NS NS NS NS
Mg x Mo NS NS NS NS
BxMgxMo NS 0.009 0.02 NS
aAmounts of boron (orthoboric acid), magnesium (magnesium acetate-4 hydrate), and molybdenum (ammonium
molybdenum oxide [para]) supplemented to the basal diet(-0.47 mg B, 25.0 mg Mg, and 0.42 mg Mo/kg). bAt age
25 days. CDistance between proximal end of the marrow sprouts and the proximal edge of the calcified extracellular
matrix. Negative values occur when calcification begins proximal to the tip of the sprouts. dNS, nonsignificant;
p>0.05.
29% in the vitamin D3-deficient animals
but only by 6% in the vitamin D3-ade-
quate control group. Further physiologic
stress, introduced as magnesium deficiency,
reversed the effect of dietary boron in the
vitamin D3-deficient chicks. Similar effects
ofdietary boron on glucose metabolism in
vitamin D3-deficient animals were noted in
three other studies. In a study designed to
test interactions among boron, magnesium,
and molybdenum in vitamin D3-deficient
chicks only (44), boron (3.47 vs 0.05
mg/kg diet) decreased plasma glucose by
21% in chicks fed either adequate amounts
ofmagnesium and no molybdenum supple-
mentation (29%) or inadequate magnesium
and supplemental molybdenum (27%)
(Table 8). Findings from a preliminary
study (45) (Table 9) with vitamin D3-defi-
cient chicks only indicated that the percent
ofdecrease in plasma glucose concentration
varied according to the amount of boron
supplementation. Compared to a basal
dietary boron concentration of0.20 mg/kg,
boron concentrations of 0.25, 0.33, 0.48,
1.23, 2.10, and 3.97 decreased glucose con-
centrations by 9, 30, 34, 29, 33, and 21%,
respectively. Second-order regression analy-
sis of the glucose values vs boron intake
described a parabola whose critical value
(slope equals 0) occurred around the point
where the milligram of boron per kilogram
of diet equaled 1.00. In vitamin D3-
deprived rats, there was a trend for boron
supplementation to decrease plasma glucose
concentrations (149 vs 134 mg/dl) (46).
Finally, a study with humans who were fed
a low-magnesium diet showed that a daily
dietary intake of 3.23 mg boron for 49
days, compared to a daily intake of0.23 mg
for 63 days, decreased serum glucose con-
centrations (in the normal range) approxi-
mately 6% (88 vs 94 mg/dl; p<0.007) in
postmenopausal women (47). In the same
study, male volunteers exhibited no
response to supplemental dietary boron.
Other findings suggest that boron mod-
ulates hepatic glycolysis, particularly when
vitamin D3 intake is inadequate. Dietary
boron (2.25 vs 0.16 mg/kg) lowered con-
centrations of the glycolytic metabolites
fructose-1,6-diphosphate-P2, glycerate-2P,
and (OH)2 -acetone P in freeze-clamped
chick liver (Table 10) (48). Furthermore,
the vitamin D3-deprived rat that is fed sup-
plemental boron (2.0 mg/kg) exhibits
reduced plasma pyruvate concentrations
(46). In summary, the evidence to date
suggests that boron acts as a regulator of
energy substrate utilization by quenching
the activity ofsome enzymes and/or stabi-
lizing reactive compounds.
Boron, Vitamin D3, and
Mineral/Growth
Cartilage Metabolism
BoneMetabolism
There is evidence that initiation ofcartilage
calcification is dependent upon the energy
charge ofthe chondrocyte. For example, in
chick epiphysial growth cartilage, creatine
kinase activity is related to chondrocyte
maturation because activity increases with
cell hypertrophy. Creatine phosphate con-
centrations are highest in the proliferative
zone and are nondetectable in calcified car-
tilage as compared to amounts present in
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Table 9. Effects of dietary boron on growth and plasma glucose in the vitamin D3-deficient chick (45).
Treatment a Plasma
Boron, Bodyweight b Glucose, Boron,
mg/kg g mg/dl pg/mI
0.200 604 496 58
0.248 662 452 60
0.334 613 349 58
0.481 695 327 82
1.231 710 352 95
2.095 725 330 131
3.973 509 400 218
Second order regression analysis-pvalues
0.010 0.001
Critical values, mg boron/kg
0.86 1.04
aAmount of boron in diet by analysis. Supplemental boron supplied as orthoboric acid. bAt age 28 days.
Table 10. Effects of dietary boron, vitamin D3 deficiency and their interaction on the concentration of selected gly-
colytic metabolites in chick liver(48).
Treatmenta Fructose-1,6- Glycerate-2- Dihydroxy-acetone
Boron Vitamin D3 biphosphate phosphate phosphate
mg/kg IU/kg pmole/g pmole/g pmole/g
0 125 0.069 0.065 0.057
0 625 0.074 0.075 0.070
3 125 0.038 0.055 0.051
3 625 0.062 0.064 0.052
Analysis ofvariance-pvalues
Boron 0.001 0.0003 0.02
Vitamin D3 0.02 0.0009 NSb
Boron xvitamin D3 NS NS NS
aAmounts of boron (orthoboric acid) and vitamin D3 supplemented to the basal diet (-0.16 mg B/kg). bNS, non-
significant; p>0.05.
Table 11. Effect of dietary boron, magnesium, and molybdenum and their interactions on bone and mineral metab-
olism in the vitamin D3-deficient chick(44).
Calcium Magnesium
Treatment a concentrations concentrations
Boron, Mg, Mo, Plasma, Femur, Plasma, Femur,
mg/kg mg/kg mg/kg pg/ml mg/g pg/ml pg/g
0 300 0 77 110 9.5 1.91
3 300 0 85 116 10.0 1.94
0 300 20 74 108 11.6 2.05
3 300 20 87 107 14.4 2.33
0 500 0 108 111 21.2 2.91
3 500 0 96 100 19.2 2.71
0 500 20 107 104 21.6 2.73
3 500 20 103 99 20.7 2.75
Analysis ofvariance-pvalues
Boron NSb NS NS NS
Mg 0.0001 NS 0.0001 0.0001
Mo NS NS 0.003 NS
Boron x Mg 0.01 NS 0.03 NS
Boron x Mo NS NS NS NS
Mg x Mo NS NS NS NS
Boron x Mg x Mo NS NS NS NS
aAmounts of boron (orthoboric acid), magnesium (magnesium acetate-4 hydrate), and molybdenum (ammonium
molybdenum oxide [para]) supplemented to the basal diet (-0.47 mg B, 2.50 mg Mg, and 0.42 mg Mo/kg). bNS,
nonsignificant; p>0.05.
resting and hypertrophic zones (49).
Mineralization of chick growth cartilage
begins in the perivascular region of the
marrow sprouts, a region of hypertrophic
cartilage that has a higher level ofoxidative
metabolism than chondrocytes greater than
150 iim from the vascular channels (50).
Also, redox studies of chick epiphyseal
growth cartilage show that the
NAD/NADH ratio is much higher in pro-
liferative than hypertrophic cartilage (51).
ViltaminD3 and BoneMetabolism
The rachitic chick, compared to the vitamin
D3-adequate chick, exhibits decreased crea-
tine kinase activity in the hypertrophic car-
tilage ofthe growth plate (49). In both the
proliferative and hypertrophic zones, the
induction of rickets causes a large decrease
in the actual concentration of NAD and
NADH, as well as a perturbation in the
ratio between the two. Administration of
vitamin D to the rachitic birds induces a
rapid increase in NAD and NADH in all
zones ofthe growth cartilage (51).
The findings that initiation of cartilage
calcification is energy dependent, and that
vitamin D3 regulates the energy charge of
the chondrocyte, support the thesis that the
influence of vitamin D3 on cartilage and
bone mineralization is mediated through
its role as a regulator of energy substrate
utilization. There are two important corol-
laries to the vitamin D3-energy thesis.
First, calcification is an energy intensive
process. Second, factors that modulate
energy metabolism also affect bone and
mineral metabolism.
Boron andGrowth
CartilageMetabolism
There is evidence that dietary boron modu-
lates growth-cartilage metabolism. In the
vitamin D3-deficient chick, an interaction
between dietary boron and magnesium
affected the histology ofthe tibial epiphysial
growth plate (Table 8) (44). Calcification
of growth-plate cartilage matrix normally
begins distal to the tips of marrow sprouts
that invade the hypertrophic zone of
growth cartilage from the metaphysis as a
parallel array of straight excavations. The
distance between the tips of the marrow
sprouts and the first appearance ofcalcified
matrix is a convenient measure ofthe min-
eralization rate. In the vitamin D3-deficient
chick, also stressed with magnesium inade-
quacy, boron supplementation inhibited
the initiation of cartilage calcification, but
enhanced body growth. When the chicks
were supplied with adequate dietary magne-
sium, supplemental boron enhanced initia-
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Table 12. Effect of boron, streptozotocin injection and their interaction on heart-mineral concentrations in vitamin
D3-deprived rats (53).
Treatmenta Heart
Boron, Calcium, Phosphorus, Manganese, Molybdenum
mg/kg Streptozotocin pg/g mg/g pg/g pg/g
0 - 148 9.68 1.76 0.75
2.4 - 160 10.1 1.91 1.04
0 + 148 8.90 1.80 0.92
2.4 + 144 9.32 1.67 0.65
Analysis ofvariance-pvalues
Boron NSb 0.03 NS NS
Streptozotocin 0.04 0.0001 NS NS
Boron x streptozotocin 0.05 NS 0.02 0.02
aAmounts of boron (orthoboric acid) supplemented to the basal diet (-0.06 mg B/Kg). All rats were injected with
either 1 ml citrate buffer/kg bodyweight or 75 mg streptozotocin/ml citrate buffer/kg bodyweight 3 days before
kill. bNS, nonsignificant; p>0.05.
tion of cartilage calcification and reduced
body growth. The findings indicated that
physiologic amounts ofboron may function
to modify mineral metabolism in vitamin
D3 deficiency by suppressing bone
anabolism in magnesium deficiency and
bone catabolism in magnesium adequacy.
The effects of boron on cartilage calcifica-
tion seem beneficial in both magnesium
inadequacy and adequacy because the vita-
min D3 deficiency-induced mortality was
substantially reduced by dietary boron.
Furthermore, supplemental boron alleviated
distortion of the marrow sprouts, a distor-
tion characteristic ofvitamin D3 deficiency.
Other findings from a different laboratory
indicate that in ovo injections of boron or
1,25-(OH)2 vitamin D3 reduced the abnor-
mal height ofthe growth plate ofone-day-
old chicks hatched from vitamin D3-defi-
cient eggs (52).
Boron andMineralMetabolism
Dietary boron also affects mineral metabo-
lism in blood and tissues. In the vitamin
D3-deficient chick, an interaction between
dietary boron and magnesium affected calci-
um and magnesium concentrations in plas-
ma but not in femora (Table 11) (44).
Thus, in the vitamin D3-deficient chick,
also stressed with magnesium inadequacy,
boron supplementation elevated plasma cal-
cium and magnesium concentrations. When
the chicks were supplied with adequate
dietary magnesium, supplemental boron
had the opposite effect on those plasma
mineral concentrations.
Heart mineral metabolism is also respon-
sive to physiologic amounts of dietary
boron (Table 12) (52). In the vitamin D3-
deprived rat, supplemental boron
depressed cardiac calcium but elevated
cardiac phosphorus concentrations.
Supplemental boron also elevated cardiac
manganese and molybdenum concentra-
tions in vitamin D3-deprived rats, but
depressed those concentrations in litter-
mates stressed with an injection of strep-
tozotocin. The streptozotocin injection
induced an acute phase of experimental
diabetes characterized by decreased
intestinal absorption of calcium (31) and
low concentrations ofplasma 1,25-(OH)2
vitamin D3 (54). Dietary boron probably
had an indirect effect on cardiac mineral
metabolism because supplemental boron
did not affect cardiac boron concentra-
tions (not shown).
Boron bone content correlated with
potassium and zinc concentrations in iliac
cortical bone samples, obtained from men
and women (62 ± 11 years) who suffered
from severe, untreated osteoporosis, with
at least one collapsed vertebra (55). The
investigators reported a negative
boron-potassium correlation and a posi-
tive boron-zinc correlation. Analysis of
bone from age-matched normal controls
showed no correlation between either ele-
ment and boron. Except for a positive cor-
relation between magnesium and boron in
the normal subjects, there were no other
correlations between any two elements,
although several bone minerals were ana-
lyzed (aluminum, calcium, copper, fluo-
rine, iron, potassium, magnesium, phos-
phorus, lead, silicon, strontium, and zinc).
Finally, in vitamin D-deficient rats, sup-
plemental dietary boron improved the
apparent absorption and retention of cal-
cium and phosphorus, and increased
femur magnesium concentrations (55).
Summary
There is considerable evidence that physi-
ologic amounts ofdietary boron modulate
both energy substrate utilization and min-
eral metabolism. Vitamin D3 regulates
energy substrate utilization. Current
research findings indicate that dietary
boron modifies that regulatory function.
The influence of vitamin D3 on growth-
cartilage mineralization is mediated at
least in part through its role as a regulator
of energy substrate utilization; calcifica-
tion is an energy-intensive process. There
is considerable evidence that dietary boron
alleviates perturbations in mineral metab-
olism that are characteristic ofvitamin D3
deficiency. The findings described herein
lend support to the hypothesis that boron
alleviates the symptoms of vitamin D3
deficiency by enhancing utilization or
sparing minimal supplies ofan active vita-
min D3 metabolite. Also, boron and vita-
min D3 have the same overall effect on
the local utilization ofenergy substrates. A
corollary ofthe hypothesis is that some of
the effects of dietary boron will be over-
shadowed by the effects of adequate
amounts ofdietary vitamin D3 .
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